EBV-miR-Bart1–5P directly targets the α1 catalytic subunit of AMPK and consequently regulates the AMPK/mTOR/HIF1 pathway, which impels NPC cell anomalous aerobic glycolysis and angiogenesis. The gene discussed is PRKAA2; the disease is nasopharyngeal carcinoma.